Compounds > eticlopride
Page last updated: 2024-08-24

eticlopride and nafadotride

eticlopride has been researched along with nafadotride in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's7 (87.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X1
Azaryan, AV; Clock, BJ; Cox, BM1
Amalric, M; Koob, GF; Smith, AD; Smith, DL; Zigmond, MJ1
Beardsley, PM; Cook, CD2
Beardsley, PM; Cook, CD; Newman, JL; Winfree, JC1
Floresco, SB; St Onge, JR1
Brown, RW; Cope, ZA; Lehmann, J; Sheppard, B1

Other Studies

8 other study(ies) available for eticlopride and nafadotride

ArticleYear
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
    Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21

    Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water

2003
Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.
    Neurochemical research, 1996, Volume: 21, Issue:11

    Topics: Animals; Benzazepines; Bromocriptine; Cocaine; Dopamine Antagonists; Male; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, mu; RNA, Messenger; Salicylamides; Transcription, Genetic; Up-Regulation

1996
Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm.
    Psychopharmacology, 2000, Volume: 148, Issue:4

    Topics: Animals; Conditioning, Operant; Cues; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Naphthalenes; Neostriatum; Neural Pathways; Pyrrolidines; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Substantia Nigra

2000
The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:2

    Topics: Animals; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Mice; Morphine; Motor Activity; Naphthalenes; Narcotic Antagonists; Narcotics; Pyrrolidines; Quinolines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Water

2003
Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 77, Issue:2

    Topics: Animals; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Mice; Motor Activity; Naphthalenes; Piperazines; Pyrrolidines; Quinolines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, N-Methyl-D-Aspartate; Salicylamides; Stereotyped Behavior

2004
Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2/3 antagonists.
    Behavioural pharmacology, 2004, Volume: 15, Issue:1

    Topics: Animals; Benzazepines; Brain; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flupenthixol; Heroin; Methadone; Morphine; Motivation; Nalbuphine; Naphthalenes; Piperazines; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, Opioid, mu; Salicylamides

2004
Dopaminergic modulation of risk-based decision making.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3

    Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Benzopyrans; Bromocriptine; Conditioning, Operant; Decision Making; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Naphthalenes; Oxazines; Piperazines; Pyridines; Pyrroles; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reinforcement Schedule; Risk; Salicylamides

2009
Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
    Behavioral neuroscience, 2009, Volume: 123, Issue:6

    Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Conditioning, Psychological; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Female; Hyperkinesis; Male; Motor Activity; Naphthalenes; Nicotine; Pyrrolidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Sex Characteristics

2009